ArticleCancer immunology, immunotherapy : CII2025

Inosine shapes PD-1 blockade responses and synergizes with dual PD-1/CTLA-4 immunotherapy to enhance antitumor immunity.

Yoichiro Narikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.